Catalyst Wire Dossier Catalyst Wire Dossier

DHEA (Dehydroepiandrosterone)

Dehydroepiandrosterone
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DHEA (Dehydroepiandrosterone), covering 2008-08-25 to 2016-05-18. Get the full timeline:

Most recent: Clinical Trial Update: Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention [Phase 2, Phase 3]

See pricing